Abstract:Abstract Background Although Alzheimer’s disease (AD) etiology is partially explained by the deposition of aggregated forms of β‐amyloid proteins and neurofibrillary tangles in the brain, the process that triggers the deposition of these proteins is still unknown. The neural (nNOS), endothelial (eNOS), and inducible nitric oxide synthases (iNOS) may play an important role in AD pathophysiology according to previous studies in animals. However, studies on humans are scarce. Therefore, we aimed to quantify the expression of NOS enzymes in the hippocampus of individuals with AD compared to individuals without the disease and investigate the association of NOS expression with cognition and AD‐related pathology. Method We evaluated the nNOS, eNOS, and iNOS expressions using immunohistochemistry in the cornu ammonis (CA) and the dentate gyrus (DG) from hippocampi from subjects with pure AD and sex‐matched controls. Cognitive abilities were evaluated using the Clinical Dementia Rating (CDR) and AD pathology using Braak staging for neurofibrillary tangles and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) for neuritic plaque. We used linear regression to examine the association of NOS with cognition and AD pathology. Results Sociodemographic and clinical variables were similar between the control and AD groups (Table 1). In individuals with AD, nNOS was overexpressed in the CA (β = 23.62, IC95% = 5.13;42.10, p = 0.01) and DG (β = 16.76, IC95% = 0.35;3.18, p = 0.01), while eNOS and iNOS were increased only in the CA (β = 0.93, IC95% = 0.02;1.84, p = 0.04; β = 0.19, IC95% = 0.09;0.90, p = 0.01, respectively) (Figure 1). Larger nNOS levels in the CA and DG were associated with worse cognitive abilities, higher Braak and CERAD scores (Table 2). Conclusion The nNOS, eNOS, and iNOS were increased in the hippocampi of subjects with AD. However, only nNOS overexpression was associated with cognitive impairment and AD‐related pathology.

Intrathecal Release of Nitric Oxide in Alzheimer’s Disease and Vascular Dementia

Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes

Dual role of nitric oxide in Alzheimer's disease

Vascular nitric oxide may lessen Alzheimer's risk

Increased neuronal nitric oxide synthase in Alzheimer's disease mediates spontaneous calcium signalling and divergent glutamatergic calcium responses

The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches

Increased pulmonary arteriolar tone associated with lung oxidative stress and nitric oxide in a mouse model of Alzheimer's disease

Nitric oxide impairs spatial learning and memory in a rat model of Alzheimer’s disease via disturbance of glutamate response in the hippocampal dentate gyrus during spatial learning

Impact of Nitric Oxide Bioavailability on the Progressive Cerebral and Peripheral Circulatory Impairments During Aging and Alzheimer's Disease

Role of nitric oxide in inflammation-mediated neurodegeneration.

Procognitive activity of nitric oxide inhibitors and donors in animal models

Gasotransmitter nitric oxide imaging in Alzheimer's disease and glioblastoma with diamino-cyclic-metalloiridium phosphorescence probes

Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.

Circulating arginine metabolites in Alzheimer’s disease and vascular dementia: A systematic review and meta-analysis

Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling

The emerging role of nitric oxide in the synaptic dysfunction of vascular dementia

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

Vascular oxidative stress causes neutrophil arrest in brain capillaries, leading to decreased cerebral blood flow and contributing to memory impairment in a mouse model of Alzheimerâ€™s disease

The neural nitric oxide synthase is associated with cognitive decline and Alzheimer’s disease pathology

2-(4-Methylthiazol-5-yl) Ethyl Nitrate Hydrochloride Ameliorates Cognitive Impairment via Modulation of Oxidative Stress and Nuclear Factor Kappa B (NF-κB) Signaling Pathway in Chronic Cerebral Hypoperfusion-Associated Spontaneously Hypertensive Rats

Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside